Lim et al. concluded that ALT, predicted by regression models, biochemical patterns, and trajectories, could serve as a guide in determining the need for more extensive or invasive liver disease testing in patients with rhabdomyolysis; furthermore, ALT could be used as a marker of muscle damage, and reciprocal prediction between peak CK and ALT could be performed [55,61]. This evidence concerns the gene GPT and rhabdomyolysis.